B
Braingrade is developing a diagnostic tool that utilizes advanced neuroimaging techniques to identify early biomarkers of Alzheimer's Disease. This technology aims to enhance early detection and monitoring of cognitive decline, enabling timely interventions for patients.
Updated 4 months ago
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Braingrade is developing a diagnostic tool that utilizes advanced neuroimaging techniques to identify early biomarkers of Alzheimer's Disease. This technology aims to enhance early detection and monitoring of cognitive decline, enabling timely interventions for patients.